Professor, Mashhad University of Medical Sciences, Iran
Dr. Zhila Taherzadeh is an Associate Professor of Clinical Pharmacology and Physiology at Mashhad University of Medical Sciences, Iran. She holds a Pharm.D. from the School of Pharmacy, Mashhad University of Medical Sciences, and earned her Ph.D. from the Academic Medical Center in Amsterdam, Netherlands. Her research focuses on targeted drug delivery, inflammation, and hypertension, with a special interest in traditional plant medicines.
Profile
Google Scholar
📚 Education
Dr. Zhila Taherzadeh completed her Pharm.D. at the School of Pharmacy, Mashhad University of Medical Sciences, Iran, in 1996. She pursued her Ph.D. at the Academic Medical Center in Amsterdam, Netherlands, from 2005 to 2011, specializing in Biomedical Engineering & Physics and Internal Medicine.
💼 Experience
Currently affiliated with Mashhad University of Medical Sciences, Dr. Taherzadeh serves as an Associate Professor in the Departments of Pharmacodynamics & Toxicology and Clinical Pharmacology. She holds administrative roles as Director of Educational Development Office (EDO) and Pharmacy Skills Laboratory at the university.
🔬 Research Interests
Dr. Taherzadeh’s research interests include clinical studies on traditional plant medicines, inflammation, immune system polarization, educational research, and hypertension-related vascular function and structure.
🏅 Awards
Throughout her career, Dr. Taherzadeh has received several accolades, including the Honor Researcher Student award at the 2nd Iranian Pharm.D. Students Seminar in Mashhad, Iran, in 1995.
📄 Publications
Brewster LM, Perrotta ID, van Montfrans GA. Should women have lower thresholds for hypertension diagnosis and treatment? J Hum Hypertens. 2023 Aug;37(8):753-754. Link
Piranaghl H, et al. The potential therapeutic impact of a topical bacteriophage preparation in treating Pseudomonas aeruginosa-infected burn wounds in mice. Heliyon. 2023;9(7)
Naserifar M, et al. Modified POPI Criteria to Assess the Quality of Prescriptions to Pediatric Patients. Iran J Pediatr. 2023;33(2)
Karizi SR, et al. A randomized, double-blind placebo-controlled add-on trial to assess the efficacy, safety, and anti-atherogenic effect of spirulina platensis in patients with inadequately controlled type 2 diabetes mellitus. Phytother Res. 2023;37(4):1435-1448. Link
Hejazi Y, et al. The Effect of Practice Prescription E-Learning System on Learning and Motivation of Pharmacy Students. Technol Knowl Learn. 2023. Link